Two classes of T lymphocytes can be distinguished: the cytotoxic T-lymphocytes characterized by the expression of CD8, which target and destroy infected cells when activated, and the CD4+ helper T-lymphocytes, which activate CD8+ T cells, promote the anti-tumor response, and catalyze the humoral immune response. This evidence concerns the gene CD8A and neoplasm.